Cargando…

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis

INTRODUCTION: Bone mass density (BMD) is still the gold standard for the diagnosis of osteoporosis, but bone turnover markers (BTMs) can provide helpful information regarding the bone remodeling process. The aim of this study was to determine the correlations between BMD and serum levels of BTMs (ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mederle, Ovidiu Alexandru, Balas, Melania, Ioanoviciu, Sorin Dumitru, Gurban, Camelia-Vidita, Tudor, Anca, Borza, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080660/ https://www.ncbi.nlm.nih.gov/pubmed/30122910 http://dx.doi.org/10.2147/CIA.S170111

Ejemplares similares

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
por: Sánchez, A., et al.
Publicado: (2016)

Magnesium Intake Predicts Bone Turnover in Postmenopausal Black South African Women
por: Wright, Hattie H., et al.
Publicado: (2019)

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2009)

Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
por: Khanizadeh, Fatemeh, et al.
Publicado: (2018)

Effect of Traditional Chinese Medicine Product, QiangGuYin, on Bone Mineral Density and Bone Turnover in Chinese Postmenopausal Osteoporosis
por: Shi, Zhen-Yu, et al.
Publicado: (2017)

Association of Serum Periostin Level with Classical Bone Turnover Markers and Bone Mineral Density in Shanghai Chinese Postmenopausal Women with Osteoporosis
por: Li, Ran, et al.
Publicado: (2021)

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis
por: Ishikawa, Koji, et al.
Publicado: (2016)

Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women
por: Kharroubi, Akram, et al.
Publicado: (2017)

Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women
por: Jordan, Natasha, et al.
Publicado: (2006)

Exploring the Relationship of Bone Turnover Markers and Bone Mineral Density in Community-Dwelling Postmenopausal Women
por: Wei, Xu, et al.
Publicado: (2021)

Relationship Among Panoramic Radiography Findings, Biochemical Markers of Bone Turnover and Hip BMD in the Diagnosis of Postmenopausal Osteoporosis
por: Johari Khatoonabad, M., et al.
Publicado: (2011)

Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women Subjected to an Aqua Fitness Training Program
por: Wochna, Krystian, et al.
Publicado: (2019)

Associations of long chain polyunsaturated fatty acids with bone mineral density and bone turnover in postmenopausal women
por: Feehan, Orlagh, et al.
Publicado: (2022)

Effect of Alkaline Drinking Water on Bone Density of Postmenopausal Women with Osteoporosis
por: Fasihi, Sanaz, et al.
Publicado: (2021)

Relation between Biochemical Parameters and Bone Density in Postmenopausal Women with Osteoporosis
por: Salamat, Mohammad Reza, et al.
Publicado: (2023)

Bone turnover markers: Emerging tool in the management of osteoporosis
por: Shetty, Sahana, et al.
Publicado: (2016)

Clinical Application of Bone Turnover Markers in Osteoporosis in Korea
por: Park, So Young, et al.
Publicado: (2019)

Associations of LRP5 Gene With Bone Mineral Density, Bone Turnover Markers, and Fractures in the Elderly With Osteoporosis
por: Wang, Qi-Fei, et al.
Publicado: (2020)

Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
por: Sugimoto, T., et al.
Publicado: (2013)

Relationship of serum GDF11 levels with bone mineral density and bone turnover markers in postmenopausal Chinese women
por: Chen, Yusi, et al.
Publicado: (2016)

The role of bone turnover markers in screening low bone mineral density and their relationship with fracture risk in the postmenopausal period
por: Mobasseri, Majid, et al.
Publicado: (2023)

The Association Between the Concentration of Serum Magnesium and Postmenopausal Osteoporosis
por: Chang, Jinlei, et al.
Publicado: (2020)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
por: Chen, Yi, et al.
Publicado: (2021)

Position Statement on the Use of Bone Turnover Markers for Osteoporosis Treatment
por: Park, So Young, et al.
Publicado: (2019)

Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
por: Peng, Jia, et al.
Publicado: (2021)

Modulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2015)

Disease Systems Analysis of Bone Mineral Density and Bone Turnover Markers in Response to Alendronate, Placebo, and Washout in Postmenopausal Women
por: Berkhout, J, et al.
Publicado: (2016)

Establishing Reference Intervals for Bone Turnover Markers in the Healthy Shanghai Population and the Relationship with Bone Mineral Density in Postmenopausal Women
por: Hu, Wei-Wei, et al.
Publicado: (2013)

Perirenalfat thickness is associated with bone turnover markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus
por: Wang, Wei, et al.
Publicado: (2022)

Influence of Obesity on Bone Turnover Markers and Fracture Risk in Postmenopausal Women
por: López-Gómez, Juan J., et al.
Publicado: (2022)

Use of Bone Turnover Markers in Clinical Practice for the Management of Osteoporosis in Korea: From the Survey on the Prescription Pattern of Bone Turnover Markers
por: Ahn, Seong Hee, et al.
Publicado: (2019)

Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis
por: He, Jianquan, et al.
Publicado: (2020)

Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2008)

Associations of IDUA and PTCH1 with Bone Mineral Density, Bone Turnover Markers, and Fractures in Chinese Elderly Patients with Osteoporosis
por: Wang, Qifei, et al.
Publicado: (2019)

The use of bone turnover markers for monitoring the treatment of osteoporosis in postmenopausal females undergoing total knee arthroplasty: a prospective randomized study
por: Ma, Rui, et al.
Publicado: (2021)

Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
por: Hu, Mingwei, et al.
Publicado: (2023)

Biochemical Bone Turnover Markers and Osteoporosis in Older Men: Where Are We?
por: Szulc, Pawel
Publicado: (2011)

Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
por: Kang, Taewook, et al.
Publicado: (2022)

Association of a history of gestational diabetes mellitus with osteoporosis, bone mineral density, and trabecular bone score in postmenopausal women
por: Lu, Boqi, et al.
Publicado: (2023)

Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
por: Shiraki, M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fl3r776mr77rr0r9pj1bn98dt8